Recovery from toxicity associated with high-dose methotrexate: prognostic factors.
D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D003681:Dehydration / Q000150:complications; D004359:Drug Therapy, Combination; D005260:Female; D006402:Hematologic Diseases / Q000139:chemically induced / Q000150:complications; D006801:Humans; D006863:Hydrogen-Ion Concentration; D066298:In Vitro Techniques; D007223:Infant; D007674:Kidney Diseases / Q000150:complications; D007677:Kidney Function Tests; D002955:Leucovorin / Q000008:administration & dosage / Q000627:therapeutic use; D008107:Liver Diseases / Q000150:complications; D008111:Liver Function Tests; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D009369:Neoplasms / Q000188:drug therapy; D010996:Pleural Effusion / Q000150:complications; D011379:Prognosis; D013997:Time Factors; D014839:Vomiting / Q000150:complications
D002955:Leucovorin; D008727:Methotrexate